Elevated liver enzymes, often identified by abnormal transaminase values (AST, ALT), are a common laboratory finding that signals hepatocellular injury or metabolic stress. Accurate ICD-10 coding for Elevation of liver transaminase levels is critical because it drives clinical communication, justifies medical necessity for testing and treatment, and influences reimbursement and quality reporting.
For revenue cycle and compliance teams, selecting the correct diagnosis code reduces denials, supports utilization review, and ensures appropriate risk adjustment when applicable. This article explains what the ICD-10-CM representation of elevated liver enzymes denotes, when to apply it, when not to, related codes, practical documentation tips, and billing considerations to optimize claim acceptance and audit readiness.
The ICD-10-CM Code for Elevation of liver transaminase levels is R74.01.
Elevation of liver transaminase levels refers to an increase in serum aminotransferases — primarily alanine aminotransferase (ALT) and aspartate aminotransferase (AST) — indicating hepatocellular injury or stress. Clinically, this finding can be transient or persistent, asymptomatic or accompanied by symptoms such as fatigue, right upper quadrant pain, jaundice, or systemic illness. In the ICD-10-CM classification, R74.01 is a symptomatic/laboratory-based code used to report the abnormal transaminase laboratory result itself when no more specific underlying cause is documented. Use of R74.01 signals an abnormal lab finding rather than a definitive diagnosis such as viral hepatitis, alcoholic liver disease, or drug-induced liver injury.
The ICD-10-CM Code for Elevation of liver transaminase levels is R74.01.
Use R74.01 when a patient presents with elevated AST and/or ALT values, the clinician documents the abnormal transaminase result as the reason for the encounter, and no specific cause (infectious, toxic, metabolic, or structural) is established during that visit. This applies to initial evaluations where laboratory abnormality drives further workup.
Use R74.01 for follow-up visits focused on trending abnormal transaminase values where the clinician documents persistent or resolving elevated liver enzymes but does not assign a definitive underlying diagnosis. This is appropriate when ordered labs and clinical assessment are intended to monitor enzyme trajectory.
Use R74.01 in low-complexity outpatient encounters where symptoms (e.g., mild abdominal discomfort) lead to labs demonstrating elevated transaminases and the provider documents the lab abnormality as the primary problem without specifying etiology. Billing for associated low-level E/M services should reflect medical decision-making tied to the abnormal lab.
Do not use R74.01 when a specific liver disease is identified and documented (for example, acute viral hepatitis, alcoholic hepatitis, nonalcoholic steatohepatitis). Instead, code the confirmed etiologic diagnosis (such as K71.6 for toxic liver disease with hepatitis or B19.9 for unspecified viral hepatitis if appropriate) because an etiologic diagnosis takes precedence over an abnormal laboratory finding.
Do not use R74.01 when elevated transaminases are documented as secondary to another clearly defined diagnosis being treated during the encounter (for example, myocardial infarction causing AST elevation or rhabdomyolysis affecting AST). In those cases, code the primary condition driving care and, if necessary, include the abnormal laboratory value as an additional code only when it impacts management.
Do not use R74.01 when documentation specifies a different abnormal liver-related lab that has a more precise code (for example, pathological bilirubin elevation with clinical jaundice coded to R17). Choose the code that best represents the documented abnormality and clinical intent.
Do not use R74.01 if documentation supports chronic liver disease (for example, cirrhosis, chronic hepatitis) with active management or complications. Use the chronic disease code (such as K74.x series) because chronic conditions should be coded over isolated lab abnormalities when both are documented.
| Condition | Code | When It Is Used | When It Is Not Used |
|---|---|---|---|
| Elevation of liver transaminase levels | R74.01 | When clinician documents elevated AST/ALT as the primary problem or lab abnormality without assigning a specific underlying cause; used for initial evaluation or monitoring of transaminase elevation. | Not used when a specific hepatic etiology is documented, when elevation is secondary to a nonhepatic primary diagnosis, or when a more precise lab abnormality code applies. |
| Nonspecific elevation of transaminases and lactic dehydrogenase | R74.0 | When documentation records nonspecific elevation of transaminases and LDH without further specificity or identified cause; used when lab abnormalities are broader than isolated ALT/AST elevation. | Not used when transaminase elevations are specified (use R74.01) or when an etiologic liver disease is documented. |
| Other abnormal serum enzyme levels | R74.6 | When clinician documents abnormal serum liver-related enzyme levels not classified elsewhere and no specific cause is identified; appropriate for atypical enzyme panels or nonstandard assays. | Not used when documentation clearly indicates transaminase elevation (use R74.01) or when a definitive diagnosis explains the lab abnormality. |
| Liver disease, unspecified | K76.9 | When clinical documentation indicates liver disease without specification or when a more detailed diagnosis cannot be determined during the encounter and patient management focuses on liver dysfunction. | Not used for isolated lab abnormalities without clinical evidence of liver disease; do not replace R74.01 when only transaminase elevation is documented and no liver disease is diagnosed. |
Clearly document why transaminase testing was ordered (symptoms, medication monitoring, abnormal prior labs). Explicit linkage between clinical signs/symptoms and the lab test supports medical necessity and reduces denials.
Note temporality (new vs. chronic), symptom status, and whether the abnormal result is persistent or resolving. Payers and auditors evaluate medical necessity in context; distinguishing acute abnormality from chronic disease guides correct code selection.
When evaluation reveals a specific etiology (infectious, toxic, autoimmune, metabolic), code that primary diagnosis in addition to or instead of R74.01 as appropriate. Specific etiologic codes carry higher clinical specificity and justify treatment-related services.
Ensure orders, lab results, and clinician interpretation are integrated and contemporaneous in documentation. When labs drive care decisions, a clear trail establishes necessity for testing and supports claim adjudication.
Leverage CombineHealth.ai’s AI-powered platform and its claim-scrubbing and coding validation capabilities to detect coding inconsistencies before submission. Automated reviews can flag inappropriate use of R74.01, missing etiologic codes, and documentation gaps that lead to denials, improving first-pass acceptance.
Coding for elevated liver enzymes has direct impact on revenue cycle outcomes:
Accurate ICD-10 coding is critical for healthcare revenue cycle performance. CombineHealth.ai's AI-powered platform helps RCM teams ensure coding accuracy, reduce denials, and optimize reimbursement through intelligent denial management and claim validation. CombineHealth.ai's intelligent platform provides automated claim scrubbing and coding validation to catch errors before submission, reducing denials and improving first-pass acceptance rates.
Q1: What is the ICD-10 code for elevated liver enzymes?
The ICD-10-CM code for elevated liver enzymes (Elevation of liver transaminase levels) is R74.01. Use this code when elevated AST and/or ALT are documented as the problem and no specific underlying hepatic diagnosis is recorded.
Q2: When should I use R74.01 vs related codes?
Use R74.01 when transaminase elevation is the documented abnormality without an identified cause. Use R74.0 for nonspecific transaminase and LDH elevations, R74.6 for other abnormal serum enzyme levels, and condition-specific ICD-10 codes (for example, codes for viral hepatitis, toxic liver disease, or cirrhosis) when an underlying etiology is confirmed.
Q3: What documentation is required when coding for elevated liver enzymes?
Document the lab values, date of testing, clinical rationale for testing (symptoms, medication monitoring, abnormal prior labs), clinician interpretation, and the plan of care. If a specific cause is identified, document diagnostic evidence and use the etiologic code.
Q4: What are common denial reasons when coding for elevated liver enzymes?
Denials commonly arise from lack of documented medical necessity, failure to link labs to clinical symptoms or monitoring rationale, omission of a specific diagnosis when available, and inconsistencies between orders, results, and clinician notes. See our guide on denial management for strategies to prevent and resolve these denials.